More cases of rare blood clots, but regulator says benefits still outweigh risk

More cases of rare blood clots, but regulator says benefits still outweigh risk

Belfast Telegraph

Published

The number of cases of rare blood clots among the millions of people in the UK who have had the Oxford/AstraZeneca vaccine has risen to 168.

Full Article